ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989

Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured

June 16, 1989